Purchase Order 75N93020P01105

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $341,700 on August 17, 2020 to procure a NextSeq 2000 sequencing system in support of COVID-19 research. The order carries firm fixed-price pricing with no set-aside. Performance occurs in San Diego, California, with an ultimate completion date of December 31, 2020. The procurement was designated under the Coronavirus COVID-19 National Interest Action Code.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc., valued at $13,724.10, for a MiSeq Reagent Kit V3 (600-cycle) on September 2, 2020. Place of performance is Bethesda, Maryland. The order was firm fixed-price with an ultimate completion date of October 3, 2020 and was funded under the Coronavirus COVID-19 National Interest Action Code.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Illumina, Inc. on July 29, 2020, for HiSeq 3000/4000SBS kit (300 cycles) and MiSeq reagent kit V2 (300 cycle) with a ceiling value of $13,569.20.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed price and ultimate completion date of September 1, 2020. No set-aside was used.</p>

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.98 million firm fixed price delivery order to Illumina, Inc. under an unidentified multiple award contract vehicle. The order is for reagents, kits, and library preparation supplies from Illumina to support COVID-19 research and sequencing efforts. Specifically, Illumina will provide 172 NovaSeq 6000 S4 reagent kits, four Nextera DNA Flex library preparation kits, four IDT for Illumina...

Illumina, Inc. was awarded a $898,275 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an Illumina NovaSeq 6000 sequencing system. The contract is in support of the Department of Health and Human Services' efforts responding to the Coronavirus Disease 2019 pandemic and will run from September 2021 through September 2022. Performance will take place in San Diego, California. No set-aside designation or...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 for an Illumina reagent kit, with an award date of August 12, 2020 and completion date of September 11, 2020. The order is firm fixed price with no set-aside. Place of performance is San Diego, California.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Illumina, Inc. on July 29, 2020, with a ceiling value of $24,607.70 for NextSeq compatible unique dual indexes A-D, NovaSeq XP 2-lane kit, and NovaSeq 5000/6000 S1 reagent kit (300 cycles).</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 1, 2020. No set-aside was used.</p>

This is a firm fixed price delivery order contract awarded to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $12,102.05 contract is for the provision of COVID-19 NovaSeq 6000 S4 Reagent Kit V1.5, with a period of performance ending on September 9, 2023. Illumina has a history of providing sequencing equipment, reagents, and related services...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for sequencing kits valued at $19,072.05, with an award date of April 13, 2021 and completion date of May 12, 2021. Performance occurs in San Diego, California. The order is firm fixed price with no set-aside designation.</p>